Groenier, K.H.

patient antibody 7\6-35 carcinoma stage anti-e cancer peptide lesion lesion size control anti-e 7 positivity pretreatment sera analysis prevalence peptide e 7\6-35 tumour papillomaviru positivity prevalence rate presence figo stages disease anti-e 7\6-35 positivity grade lymph node metastases pretreatment carcinoma patients lymph e 7\6-35 group protein regression analysis cancer patients cox regression model anti-e 7\6-35 antibodies indices survival value clinicopathological regression nodal spread clinicopathological indices groningen correlation department papillomavirus type 16 result women anti-e 7\6-35 amsterdam table status prognosis netherland study bivariate antigen treatment 6-35 tumour lesions invasion 300 patients prognostic antie 7\6-35 antibodies lymph node involvement stage iv patients metastase anti-e 7\ 6-35 antie centre ssdz e 7 proteins virol histological grade -16 lymph node status prognostic value e 7 antigens control group university